UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Affordable Care Act’s Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review

JNCI : Journal of the National Cancer Institute, 2020-08, Vol.112 (8), p.779-791

2020

Volltextzugriff (PDF)

The Clinical Trial Conundrum for Gynecologic Cancers

Obstetrics and gynecology (New York. 1953), 2023-09

2023

Volltextzugriff (PDF)

Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act

Gynecologic oncology, 2017-09, Vol.146 (3), p.457-464

2017

Volltextzugriff (PDF)

Geographic variation in the rate and route of hysterectomy for benign disease in the USA: A retrospective cross‐sectional study

BJOG : an international journal of obstetrics and gynaecology, 2023-11, Vol.130 (12), p.1502-1510

2023

Volltextzugriff (PDF)

Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research

Gynecologic oncology, 2019-03, Vol.152 (3), p.533-539

2019

Volltextzugriff (PDF)

Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4129-4143

2022

Volltextzugriff (PDF)

Catastrophic Health Expenditures With Pregnancy and Delivery in the United States

Obstetrics and gynecology (New York. 1953), 2022-04, Vol.139 (4), p.509

2022

Volltextzugriff (PDF)

Declines in health insurance among cancer survivors since the 2016 US elections

The lancet oncology, 2020-11, Vol.21 (11), p.e517-e517

2020

Volltextzugriff (PDF)

Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2023-12

2023

Volltextzugriff (PDF)

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

Journal of clinical oncology, 2017-12, Vol.35 (36), p.3999-4002

2017

Volltextzugriff (PDF)

The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care

Gynecologic oncology, 2018-01, Vol.148 (1), p.12-18

2018

Volltextzugriff (PDF)

Congressional Expansion of Enhancing Breast Cancer Screening and Care at the Veterans Health Administration

Military medicine, 2024-07, Vol.189 (7-8), p.186-189

2024

Volltextzugriff (PDF)

Care of the pregnant patient with cancer should include unfettered access to abortion

Cancer, 2023-05, Vol.129 (10), p.1473-1475

2023

Volltextzugriff (PDF)

Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis

American journal of obstetrics and gynecology, 2021-02, Vol.224 (2), p.195.e1-195.e17

2021

Volltextzugriff (PDF)

Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer

American journal of obstetrics and gynecology, 2024-09

2024

Volltextzugriff (PDF)

Adherence to PARP inhibitor therapy among women with ovarian cancer

Gynecologic oncology, 2021-11, Vol.163 (2), p.262-268

2021

Volltextzugriff (PDF)

Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States

American journal of obstetrics and gynecology, 2022-03, Vol.226 (3), p.384.e1-384.e13

2022

Volltextzugriff (PDF)

Out-of-network bills among privately insured patients undergoing hysterectomy

American journal of obstetrics and gynecology, 2022-04, Vol.226 (4), p.543.e1-543.e45

2022

Volltextzugriff (PDF)

Cost-effectiveness analysis comparing “PARP inhibitors-for-all” to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer

Gynecologic oncology, 2020-11, Vol.159 (2), p.483-490

2020

Volltextzugriff (PDF)

Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer

Gynecologic oncology, 2021-10, Vol.163 (1), p.50-56

2021

Volltextzugriff (PDF)

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

Gynecologic oncology, 2017-06, Vol.145 (3), p.549-554

2017

Volltextzugriff (PDF)

Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database

Gynecologic oncology, 2022-05, Vol.165 (2), p.309-316

2022

Volltextzugriff (PDF)

Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis

American journal of obstetrics and gynecology, 2021-09, Vol.225 (3), p.237.e1-237.e24

2021

Volltextzugriff (PDF)

Evaluation of Surgical Morbidity After Hysterectomy During an Obesity Epidemic

Obstetrics and gynecology (New York. 1953), 2022-04, Vol.139 (4), p.589

2022

Volltextzugriff (PDF)

U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis

Obstetrics and gynecology (New York. 1953), 2019-04, Vol.133 (4), p.795-802

2019

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(112)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(85)
Humans
(69)
Female
(49)
Obstetrics & Gynecology
(37)
Oncology
(37)
Middle Aged
(23)
Adult
(19)
United States - Epidemiology
(18)
Retrospective Studies
(16)
United States
(15)
Aged
(14)
Adolescent
(11)
Male
(10)
General & Internal Medicine
(9)
Patient Protection And Affordable Care Act
(9)
Young Adult
(9)
Insurance Coverage
(8)
Neoplasms - Therapy
(8)
Ovarian Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The Affordable Care Act’s Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review

The Clinical Trial Conundrum for Gynecologic Cancers

Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act

Geographic variation in the rate and route of hysterectomy for benign disease in the USA: A retrospective cross‐sectional study

Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research

Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis

Catastrophic Health Expenditures With Pregnancy and Delivery in the United States

Declines in health insurance among cancer survivors since the 2016 US elections

Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer: A Randomized Controlled Trial

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care

Congressional Expansion of Enhancing Breast Cancer Screening and Care at the Veterans Health Administration

Care of the pregnant patient with cancer should include unfettered access to abortion

Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis

Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer

Adherence to PARP inhibitor therapy among women with ovarian cancer

Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States

Out-of-network bills among privately insured patients undergoing hysterectomy

Cost-effectiveness analysis comparing “PARP inhibitors-for-all” to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer

Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer

Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers

Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database

Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis

Evaluation of Surgical Morbidity After Hysterectomy During an Obesity Epidemic

U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis

Suchergebnisse filtern